In April 2005, the FDA approved the first GLP1 analogue, exenatide (Byetta ... and side-effect profile. Liraglutide, an acylated GLP1 analogue that requires daily dosing, is another incretin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback